Skip to content

Posters advertising a variety of clinical research trials at Penn State College of Medicine are seen on a College bulletin board in summer 2016. The image shows five posters in a line, with the center one in focus and the others out-of-focus in the background.

Infectious Diseases Clinical Studies

Learn More

The StudyFinder logo for Penn State University is the words Study and Finder on two lines in two shades of blue. The dot over the I is an open circle, giving the appearance of the I being a person.
See active clinical trials on StudyFinder

The Division of Infectious Diseases and Epidemiology at Penn State College of Medicine leads clinical research studies to determine the usefulness of new treatments and infection prevention protocols.

Current Studies

View active infectious diseases clinical trials in StudyFinder, our searchable database of clinical research taking place at Penn State Health Milton S. Hershey Medical Center and Penn State College of Medicine.

Learn More About Clinical Research

Jump to topic

Search

Open Clinical Studies

Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE) Expand answer

Sponsors and Collaborators: University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID) 

Site Principle Investigator: Catharine I. Paules, MD

ID Division investigators: Catharine I. Paules, MD, Rezhan Hussein, MD, Kathleen Julian, MD

Lead study coordinator: Michael Klemick, BS

This study is for people in the hospital with COVID-19 and will assess an investigational anti-viral (S-217622, an anti-SARS-CoV2 3C-like protease inhibitor). The study design is a randomized, placebo-controlled, multi-center international clinical trial that will evaluate the clinical efficacy of S-217622 when added to standard of care therapies.

ClinicalTrials.gov Identifier: NCT05605093

For more information on this study, please contact: Dr. Paules at 717-531-8881 (or via Tiger Text) or lead study coordinator Michael Klemick at 717-531-0003, ext. 282268 (or via Tiger Text).

Contact

To speak to someone about our current studies, please call 717-531-8881.